References
- PascoeSLocantoreNDransfieldMTBarnesNCPavordIDBlood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trialsLancet Respir Med20153643544225878028
- SiddiquiSHGuasconiAVestboJBlood eosinophils: a bio-marker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2015192452352526051430
- PavordIDLettisSLocantoreNBlood eosinophils and inhaled corticosteroid/long-acting beta-2 agonist efficacy in COPDThorax201671211812526585525
- BafadhelMMcKennaSTerrySBlood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trialAm J Respir Crit Care Med20121861485522447964
- BafadhelMDaviesLCalverleyPMAaronSDBrightlingCEPavordIDBlood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysisEur Respir J201444378979124925917
- BarnesNSharmaRLettisSCalverleyPMBlood eosinophils as a marker of response to inhaled corticosteroids in COPDEur Respir J20164751374138226917606
- WatzHTetzlaffKWoutersEFBlood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialLancet Respir Med20164539039827066739
- HizawaNClinical approaches towards asthma and chronic obstructive pulmonary disease based on the heterogeneity of disease pathogenesisClin Exp Allergy201646567868727009427
- Global Strategy for the Diagnosis, Management and Prevention of COPD [homepage on the Internet]Global Initiative for Chronic Obstructive Lung Disease (GOLD)2017 Available from: http://goldcopd.orgAccessed January 16, 2017
- BainBSeedMGodslandINormal values for peripheral blood white cell counts in women of four different ethnic originsJ Clin Pathol19843721881936693578
- ScottKAWardlawAJEosinophilic airway disordersSemin Respir Crit Care Med200627212813316612763
- MurphyKJaneway’s Immunobiology8th edNew YorkGarland Science2012
- SzeflerSJWenzelSBrownRAsthma outcomes: biomarkersJ Allergy Clin Immunol20121293 SupplS9S2322386512
- ChristensenRDHillHRExercise-induced changes in the blood concentration of leukocyte populations in teenage athletesAm J Pediatr Hematol Oncol1987921401422954481
- KreindlerJLLocantoreNWatkinsMLLettisSTal-SingerRMinimal effect of inhaled corticosteroids on blood eosinopil count in steroid-naïve COPD patients. Abstract No. 853109ERS International ConferenceAmsterdam2015
- KreindlerJLWatkinsMLLettisSTal-SingerRLocantoreNEffect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPDBMJ Open Respir Res201631e000151
- HiltonEComptonCMidwinterDBarnesNThe distribution of blood eosinophil count in a COPD clinical trials database: comparing the UK with the rest of the worldThorax201671Suppl 3A159A160
- AsaiKKobayashiAMakiharaYJohnsonMAnti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis20151080381125945045
- BetsuyakuTKatoMFujimotoKA study to assess COPD symptom-based management and to optimise treatment strategy in Japan (COSMOS-J) based on GOLD 2011Int J Chron Obstruct Pulmon Dis2013845345924124358
- SvedsaterHDalePGarrillKWalkerRWoepseMWQualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPDBMC Pulm Med2013137224314123
- CelliBCraterGKilbrideSOnce-daily umeclidinium/vilanterol 125/25 mcg in COPD: a randomized, controlled studyChest2014145598199124385182
- DonohueJFMaleki-YazdiMRKilbrideSMehtaRKalbergCChurchAEfficacy and safety of once-daily umeclidinium/vilanterol62.5/25 mcg in COPDRespir Med2013107101538154623830094
- TrivediRRichardNMehtaRChurchAUmeclidinium in patients with COPD: a randomised, placebo-controlled studyEur Respir J2014431728123949963
- TakahashiTIchinoseMInoueHShiratoKHattoriTTakishimaTUnderdiagnosis and undertreatment of COPD in primary care settingsRespirology20038450450814629656
- FukuchiYNishimuraMIchinoseMCOPD in Japan: the Nippon COPD epidemiology studyRespirology20049445846515612956
- OmoriHNonamiYMiharaSMarubayashiTMorimotoYAizawaHPrevalence of airflow limitation on medical check-up in Japanese subjectsJ UOEH200729320921917900001
- OnishiKYoshimotoDHaganGWJonesPWPrevalence of airflow limitation in outpatients with cardiovascular diseases in JapanInt J Chron Obstruct Pulmon Dis2014956356824920894
- YoshimotoDNakanoYOnishiKHaganGJonesPThe relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking historyInt J Chron Obstruct Pulmon Dis201491357136325525353
- NiWShaoXCaiXProphylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysisPLoS One201510e012125725812085
- AmayasuHYoshidaSEbanaSClarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthmaAnn Allergy Asthma Immunol20008459459810875487
- BarnesNPavordIJonesPWBlood eosinophil count as a predictor of response to inhaled corticosteroids (ICS) in COPDAm J Respir Crit Care Med2015191A3975
- GeorgeLBrightlingCEosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary diseaseTher Adv Chronic Dis201671345126770668